NEW YORK, Feb 15 – Genomic Solutions reported Thursday fourth quarter 2000 earnings of $5.5 million, up from $3.4 million in the same quarter of 1999, as the result of increased sales of the Investigator proteomic and GeneTAC biochip system and revenues from contract research performed at the company’s Proteomic Research Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.